Back to Directory
Kherion Technology
Founded 2003
Immunomodulatory therapeutics for chronic autoimmune and inflammatory diseases
Kherion Technology is a biotechnology company developing immunomodulatory treatments for chronic autoimmune and inflammatory diseases.
Its lead preclinical programme investigates a proprietary therapeutic composition intended to reduce chronic inflammation without broadly suppressing immune activity. A granted US patent covers potential treatment applications in Crohn's disease, inflammatory bowel disease and sarcoidosis.
The company is focused on preclinical autoimmune disease research, with oncology identified as a potential future development area.